In August 2017 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete after his sample tested positive for the prohibited substances 1,3-Dimethylbutylamine (1,3-DMBA) and Oxilofrine (methylsynephrine).
After notification the Athlete gave a prompt admission, waived his right to be heard, accepted a provisional suspension and the sanction proposed by the CCES.
Therefore the CCES decides on 30 October 2017 to impose a 2 year period of ineligibility on the Athlete starting on the date of the sample collection, i.e. 9 july 2017.